Renascience

Renascience EPS Growth

The EPS Growth of Renascience (4889.T) as of Nov 19, 2026 is -346.15 %. In the previous year, EPS Growth was 143.71 % — a change of -340.86% (lower).

EPS Growth

-346.15 %

YoY

-340.86%

Last updated:

EPS Growth of Renascience is 2026 -346.15 % . EPS Growth of Renascience was 2025 143.71 % . It decreases by -340.86% lower compared to the previous year.

The Renascience EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2021
45.62 JPY
Jan 1, 2022
-175.45 JPY
Jan 1, 2023
-32.05 JPY
Jan 1, 2024
23.07 JPY
Jan 1, 2025
143.71 JPY
Jan 1, 2026
-346.15 JPY
The Renascience EPS Growth history
YEAREPS GrowthYoY
-346.15 %-340.86%
143.71 %+523.00%
23.07 %-171.97%
-32.05 %-81.73%
-175.45 %-484.57%
45.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

EPS Growth of Renascience is -346.15 % in 2026.

On Eulerpool you can find the complete historical development of EPS Growth Renascience since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Renascience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Renascience

All Key Metrics — Renascience